Sahajanand Medical Technologies (SMT), a global leader in cardiovascular medical devices, has announced the appointment of Bhargav Kotadia as its Chief Executive Officer (CEO) and Jose Calle Gordo as the Chairman effective April 1st 2025.
Bhargav Kotadia (as seen in the image) succeeds Ganesh Sabat, who has played an instrumental role in SMT’s growth journey over the past 12 years. Sabat's leadership has been pivotal in expanding SMT’s global footprint, strengthening its innovation pipeline, and fostering a high-performance culture.
Dhirajlal Kotadia, SMT’s Founder and Chairman, will take on the role of Chairman Emeritus, continuing to provide strategic guidance while Jose Calle Gordo will assume the role of Chairman, working closely with Kotadia to drive SMT’s next phase of growth.
Kotadia has been closely associated with SMT’s strategic direction for last 12 years, playing a key role in shaping the company's expansion and innovation agenda. Under his leadership, SMT will remain committed to its core values of Care, Innovation, Excellence and Agility, with a continued focus on advancing cardiovascular care globally.